Use of Cordia dichotoma bark in the treatment of ulcerative colitis.

about

Favorable results from the use of herbal and plant products in inflammatory bowel disease: evidence from experimental animal studies Potential of the plant Thespesia populnea in the treatment of ulcerative colitis.

P2860

Q26745772-A46E25B0-27F0-46A8-A2F9-EDADDB257C04 Q46746015-FD31B354-7865-49A3-87D2-CBA642879A57

P2860

Use of Cordia dichotoma bark in the treatment of ulcerative colitis.

Item

http://www.wikidata.org/entity/Q47287905

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Use of Cordia dichotoma bark in the treatment of ulcerative colitis.

@en

Use of Cordia dichotoma bark in the treatment of ulcerative colitis.

@nl

type

Item

label

Use of Cordia dichotoma bark in the treatment of ulcerative colitis.

@en

Use of Cordia dichotoma bark in the treatment of ulcerative colitis.

@nl

prefLabel

Use of Cordia dichotoma bark in the treatment of ulcerative colitis.

@en

Use of Cordia dichotoma bark in the treatment of ulcerative colitis.

@nl

P1476

Use of Cordia dichotoma bark in the treatment of ulcerative colitis

@en

P2093

Anjali B Ganjare

http://www.w3.org/2001/XMLSchema#string

Ruksana A Rub

http://www.w3.org/2001/XMLSchema#string

Shashikant R Pattan

http://www.w3.org/2001/XMLSchema#string

Sunil A Nirmal

http://www.w3.org/2001/XMLSchema#string

P2860

A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay

Antioxidant activity applying an improved ABTS radical cation decolorization assay.

Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous?

Ginger--an herbal medicinal product with broad anti-inflammatory actions.

Biologic therapy for inflammatory bowel disease.

Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules

Recent developments in nonspecific inflammatory bowel disease (second of two parts).

Site-specific lesion formation, inflammation and inducible nitric oxide synthase expression by indomethacin in the rat intestine.

Depleted mucosal antioxidant defences in inflammatory bowel disease.

P304

850-855

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13880209.2010.551539

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anuja N Patil

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21696332

http://www.w3.org/2001/XMLSchema#string

Use of Cordia dichotoma bark in the treatment of ulcerative colitis.

about

P2860

P2860

Use of Cordia dichotoma bark in the treatment of ulcerative colitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698